Finance Inquirer
No Result
View All Result
Friday, July 11, 2025
  • Login
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market
Subscribe
Finance Inquirer
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market
No Result
View All Result
Finance Inquirer
No Result
View All Result
Home Finance

California Will Develop Its Own Low-Cost Insulin: Newsom

Tom Hagler by Tom Hagler
09.07.2022
in Finance
California Will Develop Its Own Low-Cost Insulin: Newsom
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

California Will Develop Its Own Low-Cost Insulin: Newsom

Authored by Mimi Nguyen Ly via The Epoch Times,

California Gov. Gavin Newsom announced on Thursday that the state will develop its own “low-cost” insulin—an essential hormone that many rely on to treat their diabetes—making the state the first in the country to pursue such an effort.

In a video shared on Twitter, he said that “people should not go into debt to receive life-saving medication.”

“Many Americans experience out-of-pocket costs anywhere from $300 to $500 per month for this life-saving drug,” he said. 

“California is now taking matters into its own hands. The budget I just signed sets aside $100 million so we can contract and make our own insulin at a cheaper price, close to at cost, and make it available to all.”

Newsom last week signed a $308 billion state budget. He said on Thursday that $50 million in the budget will go toward developing low-cost insulin products and another $50 million “will go towards a California-based insulin manufacturing facility” that he says will “provide new, high paying jobs and a stronger supply chain” for the diabetes medication.

An insulin kit. (Kerem Yucel/AFP via Getty Images)

Millions of people with diabetes, whose bodies cannot make insulin or respond well to it, use injections of the manufactured version of insulin to keep their blood sugars within normal ranges to ward off multiple health complications.

Of the 37 million people in the United States who have diabetes, about 8.4 million use insulin, according to the American Diabetes Association. Medical costs in the United States for people with diabetes are more than double those incurred by people without diabetes, and about one out of every three Medicare dollars goes to treating people with diabetes.

Earlier this month, senators in Congress introduced a bipartisan insulin bill to cap insulin costs. Senate Majority Leader Chuck Schumer (D-N.Y.) praised the bill, introduced by the co-chairs of the U.S. Senate Diabetes Caucus, Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), and said he would bring it to a vote on the Senate floor “very soon.” The bill, if passed, would take effect for those with coverage on Jan. 1, 2024.

The price of a product usually falls over time, but insulin continues to rise in cost to consumers. 

Three companies – Sanofi SA, Eli Lilly and Co., and Novo Nordisk – own some 90 percent of the market for insulin, which was first isolated in the 1920s.

About one in five insured Americans pay more than $35 per month for the treatment, while the rest pay about $23 per month, according to a 2021 report on drug prices by health information company IQVIA.

The Trump administration previously announced a program in May 2020 to cap the price of insulin for many Medicare recipients. The program went into effect in January 2021 and remains in place. Under the program, more than 1,750 Medicare Part D and Medicare Advantage plans have voluntarily capped the co-payments for insulin at $35 per month.

Tyler Durden Fri, 07/08/2022 – 14:45

  • Trending
  • Comments
  • Latest
P2Pro: profitable changes are coming!

P2Pro: profitable changes are coming!

13.09.2022
Saving and investing the two keys to your future retirement

Saving and investing the two keys to your future retirement

21.06.2022
The Dow Jones slept through the whole trade despite positive data from the labor market. Nasdaq had its best streak of gains this year

The Dow Jones slept through the whole trade despite positive data from the labor market. Nasdaq had its best streak of gains this year

01.09.2022
The ranking of countries in terms of the coverage of children with preschool education has been compiled

The ranking of countries in terms of the coverage of children with preschool education has been compiled

03.11.2022
Take the best photos of your life with the new vivo Y76 5G now available

Take the best photos of your life with the new vivo Y76 5G now available

Complete your Christmas shopping with up to 75% off on devices at vivo’s Big Christmas Sale on Shopee

Complete your Christmas shopping with up to 75% off on devices at vivo’s Big Christmas Sale on Shopee

AirPods 3 vs AirPods 2 – What’s the Difference?

AirPods 3 vs AirPods 2 – What’s the Difference?

Want to be a content creator? Here are 5 valuable tips from today’s top Pinoy online celebrities

Want to be a content creator? Here are 5 valuable tips from today’s top Pinoy online celebrities

PuzzleFree Game Set to Launch in July 2025

PuzzleFree Game Set to Launch in July 2025

08.07.2025
The $14.6 Billion Question: What the Largest Healthcare Fraud Takedown in History Means for Medical Leaders and Investors

The $14.6 Billion Question: What the Largest Healthcare Fraud Takedown in History Means for Medical Leaders and Investors

08.07.2025
Instant Cargo Analysis 24/7: How XRF Analyzer Speeds Up Quality Control for Raw Materials

Instant Cargo Analysis 24/7: How XRF Analyzer Speeds Up Quality Control for Raw Materials

08.07.2025
HIT-NOT reduces forklift accidents and increases safety in logistics

HIT-NOT reduces forklift accidents and increases safety in logistics

07.07.2025

Recent News

PuzzleFree Game Set to Launch in July 2025

PuzzleFree Game Set to Launch in July 2025

08.07.2025
The $14.6 Billion Question: What the Largest Healthcare Fraud Takedown in History Means for Medical Leaders and Investors

The $14.6 Billion Question: What the Largest Healthcare Fraud Takedown in History Means for Medical Leaders and Investors

08.07.2025

Categories

  • Business
  • Finance
  • News
  • Stock Market
  • Technology
  • Без рубрики

Site Navigation

  • Home
  • Contact Us
Finance Inquirer

We offer multimedia features, easy channel navigation, strong social media presence and numerous engagement platforms that allow the readers to experience content anytime, anywhere, always.

No Result
View All Result
  • Home
  • Business
  • Technology
  • Finance
  • Stock Market

© 2021 financeinquirer.com

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In